This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nihon Pharmaceutical Co., Ltd. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Takashi Mano: Innovator in Aesthenopia Treatment
Introduction
Takashi Mano is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of aesthenopia. His innovative approach has led to the development of a unique composition aimed at alleviating this condition.
Latest Patents
Takashi Mano holds a patent for a composition for the treatment of aesthenopia. This novel medicine, along with a food and drink composition, is designed to provide an excellent effect in improving symptoms associated with aesthenopia. The key ingredient in this composition is chondroitin sulfate or a salt thereof, which plays a crucial role in its effectiveness.
Career Highlights
Currently, Takashi Mano is associated with Nihon Pharmaceutical Co., Ltd. His work at this company has allowed him to focus on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key figure in the field.
Collaborations
Takashi Mano has collaborated with notable colleagues, including Tatsuya Wada and Masatoshi Tanouchi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
In summary, Takashi Mano is a distinguished inventor whose work in the treatment of aesthenopia has made a significant impact. His innovative compositions and collaborations highlight his commitment to advancing medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile